GLPBio

Aminoacyl-tRNA Synthetase

Read More about this category

Aminoacyl-tRNA Synthetases (AARSs) are ubiquitous and evolutionarily conserved enzymes that catalyze the highly specific acylation of amino acids to cognate tRNAs. Aminoacyl-tRNA Synthetases are essential for accurate decoding of the triplet genetic code and for sustenance of all domains of life, including bacteria, archaea, and eukarya.

Aminoacyl-tRNA Synthetases also perform critical cellular activities unrelated to their primary function in aminoacylation. These noncanonical activities include regulation of gene transcription, mRNA translational control, angiogenesis, apoptosis, amino acid sensing, and cell signaling.

Products Related to Aminoacyl-tRNA Synthetase(11)

  • GC30293 structure
    GC30293Arg-AMS
    CAS: 301351-95-1
    Purity: >98.00%

    Arg-AMS is a potent nanomolar inhibitor of arginyl tRNA synthetase, which displays tightly bound inhibitory characteristics for the A-domains in non-ribosomal peptide synthetases (NRPS) enzymes.

  • GC30683 structure
    GC30683Gln-AMS
    CAS: 209543-57-7
    Purity: >99.50%

    Gln-AMS is an aminoacyl-tRNA synthetase (AARS) inhibitor, with the K i value of 1.32μM.

  • GC31432 structure
    GC31432Asp-AMS
    CAS: 828288-98-8
    Purity: >98%

    Asp-AMS, an analogue of aspartyl-adenylate, is an aspartyl-tRNA synthetase inhibitor and also a strong competitive inhibitor of the mitochondrial enzyme.

  • GC32121 structure
    GC32121Leu-AMS
    CAS: 288591-93-5
    Purity: >99.00%

    Leu-AMS (compound 6), a leucine analogue, is a potent inhibitor of leucyl-tRNA synthetase (LRS) with an IC50 of 22.34 nM, which inhibits the catalytic activity of LRS but did not affect the leucine-induced mTORC1 activation.

  • GC32149 structure
    GC32149Aminoacyl tRNA synthetase-IN-1
    CAS: 219931-45-0
    Purity: >99.50%

    Aminoacyl tRNA synthetase-IN-1 is a bacterial aminoacyl tRNA synthetase (aaRS) inhibitor.

  • GC32366 structure
    GC32366GlyRS-IN-1
    CAS: 112921-11-6
    Purity: >98%

    GlyRS-IN-1 is a glycyl-tRNA synthase (GlyRS) inhibitor extracted from patent WO 2017066459 A1.

  • GC34331 structure
    GC34331Gln-AMS TFA
    Purity: >98%

    Gln-AMS TFA is an aminoacyl-tRNA synthetase (AARS) inhibitor, with the K i value of 1.32μM.

  • GC34358 structure
    GC34358Leu-AMS R enantiomer
    Purity: >98%

    Leu-AMS R enantiomer is the R enatiomer of Leu-AMS.

  • GC65058 structure
    GC65058LysRs-IN-2
    CAS: 2170696-76-9
    Purity: >99.50%

    LysRs-IN-2 is a lysyl-tRNA synthetase (KRS) inhibitor with IC50s of 0.015 μM and 0.13 μM for Plasmodium falciparum lysyl-tRNA synthetase (PfKRS) and Cryptosporidium parvum lysyl-tRNA synthetase (CpKRS), respectively.

  • GC79562 structure
    GC79562BC-DXI-495
    CAS: 2421117-94-2
    Purity: >99.00%

    BC-DXI-495 is a AIMP2-DX2 inhibitor.

  • GC81879 structure
    GC81879NCP26 TFA
    Purity: >99.50%

    NCP26 TFA is an ATP-competitive ProRS inhibitor (with a K D of 271 nM in the absence of proline, and a K D of 0.35 nM in the presence of 100 μM proline).